Transpharmation Ltd. in London, NW1 0NH

Description

Data updated on: 01-11-2023

Registered with number 07348226 fourteen years ago, Transpharmation Ltd. is categorised as a Private Limited Company. The firm's current mailing address is The London Bioscience Innovation Centre, 2 Royal College Street London. This enterprise's declared SIC number is 74909 and has the NACE code: Other professional, scientific and technical activities not elsewhere classified. Transpharmation Limited. reported its account information for the financial year up to December 31, 2022. The firm's latest confirmation statement was released on July 4, 2023.

Joseph A. and Mark D. are the firm's directors and have been doing everything they can to make sure everything is working correctly since 2021.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
Currency
Net Worth	40 008	86 399	316 943	377 172	531 587

Balance Sheet
Cash Bank On Hand					180 132	420 351	408 403	270 214	418 274	1 353 749	1 025 856	2 391 035	4 346 479
Current Assets	283 884	252 358	392 606	512 575	630 355	907 506	1 326 868	1 450 883	2 329 868	3 337 777	2 831 318	4 786 638	7 711 207
Debtors	124 942	107 390	60 748	307 672	450 223	487 155	918 465	1 180 669	1 911 594	1 984 028	1 805 462	2 395 603	3 364 728
Net Assets Liabilities					531 587	815 557	1 127 385	1 413 238	2 136 254	2 911 857	2 350 236	3 788 229	6 579 070
Other Debtors					21 130	62 692	128 588	137 840	74 394	164 418	49 165	39 571	13 156
Property Plant Equipment					30 499	49 084	91 535	170 060	46 374	92 356	92 366	55 063	19 557
Cash Bank In Hand	158 942	144 968	331 858	204 903	180 132
Net Assets Liabilities Including Pension Asset Liability	40 008	86 399	316 943	377 172	531 587
Tangible Fixed Assets	4 667	10 599	24 352	36 887	30 499

Capital & Reserves
Called Up Share Capital	100	100	100	100	100
Profit Loss Account Reserve	39 908	86 299	316 843	377 072	531 487
Shareholder Funds	40 008	86 399	316 943	377 172	531 587

Other Financial Data
Accumulated Depreciation Impairment Property Plant Equipment					53 843	82 750	127 809	204 026	189 598	244 365	295 169	340 776	383 133
Additions Other Than Through Business Combinations Property Plant Equipment						47 492		154 742	76 536	100 771	50 814	11 304	6 851
Amounts Owed By Group Undertakings Participating Interests					101 247	161 622	259 553	371 242	1 143 600	1 191 282	1 031 096	1 340 900	1 776 869
Average Number Employees During Period								14	15	18	20	25	24
Creditors					129 350	141 116	291 101	207 788	240 071	518 359	575 249	1 055 273	1 153 495
Fixed Assets	4 667	10 599	24 352	36 970	30 582	49 167	91 618	170 143	46 457	92 439	94 167	56 864	21 358
Increase From Depreciation Charge For Year Property Plant Equipment						28 907		76 217	200 222	54 767	50 804	45 607	42 357
Investments Fixed Assets				83	83	83	83	83	83	83	1 801	1 801	1 801
Net Current Assets Liabilities	35 341	75 800	292 591	340 202	501 005	766 390	1 035 767	1 243 095	2 089 797	2 819 418	2 256 069	3 731 365	6 557 712
Other Creditors					49 826	20 207	110 866	66 236	79 248	214 202	370 885	645 742	815 250
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment									214 650
Other Disposals Property Plant Equipment									214 650	22		3 000
Other Taxation Social Security Payable					44 587	44 471	55 920	37 718	89 291	144 729	196 219	237 060	178 749
Property Plant Equipment Gross Cost					84 342	131 834	219 344	374 086	235 972	336 721	387 535	395 839	402 690
Trade Creditors Trade Payables					34 937	76 438	124 315	103 834	71 532	159 428	8 145	172 471	159 496
Trade Debtors Trade Receivables					327 846	222 138	487 151	609 735	521 187	368 566	725 201	963 745	1 574 703
Creditors Due Within One Year	248 543	176 558	100 015	172 373	129 350
Tangible Fixed Assets Additions		10 388	24 382	30 212	12 956
Tangible Fixed Assets Cost Or Valuation	6 403	16 792	41 174	71 386	84 342
Tangible Fixed Assets Depreciation	1 736	6 192	16 822	34 499	53 843
Tangible Fixed Assets Depreciation Charged In Period		4 456	10 629	17 677	19 344
Total Assets Less Current Liabilities	40 008	86 399	316 943	377 172	531 587

Company staff

Joseph A.

Role: Director

Appointed: 16 September 2021

Latest update: 21 June 2024

1/2 or less of shares

Mark D.

Notified on 1 July 2016

Ceased on 3 December 2021

Nature of control:

1/2 or less of shares

Vivocore Inc.

Address: 66 Wellington Street West, Suite 4100, Toronto, Ontario, M5K 1B7, Canada

Legal authority Incoroporate Company Act

Legal form Incororated

Country registered Canada

Place registered Canda

Registration number 11692305

Notified on 17 August 2021

Ceased on 1 December 2021

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	18 July 2024
Confirmation statement last made up date	04 July 2023

Annual Accounts 10 May 2013
Start Date For Period Covered By Report	2012-01-01
End Date For Period Covered By Report	2012-12-31
Date Approval Accounts	10 May 2013
Annual Accounts 19 September 2014
Start Date For Period Covered By Report	2013-01-01
End Date For Period Covered By Report	2013-12-31
Date Approval Accounts	19 September 2014
Annual Accounts 14 August 2015
Start Date For Period Covered By Report	2014-01-01
End Date For Period Covered By Report	2014-12-31
Date Approval Accounts	14 August 2015
Annual Accounts 30 September 2016
Start Date For Period Covered By Report	2015-01-01
End Date For Period Covered By Report	2015-12-31
Date Approval Accounts	30 September 2016
Annual Accounts
Start Date For Period Covered By Report	2017-01-01
End Date For Period Covered By Report	31 December 2017
Annual Accounts
Start Date For Period Covered By Report	2018-01-01
End Date For Period Covered By Report	31 December 2018
Annual Accounts
Start Date For Period Covered By Report	2019-01-01
End Date For Period Covered By Report	31 December 2019
Annual Accounts
Start Date For Period Covered By Report	2020-01-01
End Date For Period Covered By Report	31 December 2020
Annual Accounts
Start Date For Period Covered By Report	2021-01-01
End Date For Period Covered By Report	31 December 2021
Annual Accounts
Start Date For Period Covered By Report	2022-01-01
End Date For Period Covered By Report	31 December 2022
Annual Accounts
Start Date For Period Covered By Report	2023-01-01
End Date For Period Covered By Report	31 December 2023
Annual Accounts
End Date For Period Covered By Report	31 December 2016

Transpharmation Ltd.

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Joseph A.

Mark D.

Karen L.

Susan U.

Neil U.

Karen L.

People with significant control

Joseph A.

Mark D.

Vivocore Inc.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies